OBJECTIVE:To evaluate clinical efficacy of point application or adjuvant therapy on chronic obstructive pulmonary disease in stationary phase and effects on pulmonary functions.METHODS:Computer retrieved CNKI,VIP,CBM ...OBJECTIVE:To evaluate clinical efficacy of point application or adjuvant therapy on chronic obstructive pulmonary disease in stationary phase and effects on pulmonary functions.METHODS:Computer retrieved CNKI,VIP,CBM and other databanks and manual operations retrieved correlative literatures to find randomized controlled trials(RCTs) about comparison between point application or adjuvant therapy and no-point-applications for treatment of chronic obstructive pulmonary disease in stationary phase in China.RevMan 5.0 software was used for Meta analysis.RESULTS:Among 3481 cases in the inclusive 32 RCTS,1780 cases were in the test group and 1701 cases in the control group.Meta analysis indicated:1) clinical efficacy:the groups containing point application therapy all were better than the groups of no-point-application;2) force vital capacity(FVC):There was no statistically significant difference between the group of point application plus Western Medicine and the Western Medicine group;3) force expiratory volume 1(FEV1):The groups containing point application therapy were better than the no-point-application;4) FEV1%:the groups of point application plus Western Medicine were better than the Western Medicine groups;5) FEV1/FVC:there was a significant difference between the group of point application plus Chinese drugs and the group of Chinese drug.CONCLUSION:Point application can increase clinical efficacy of chronic obstructive pulmonary disease in stationary phase in varying degrees,and different combinations of point application with Chinese drugs or Western Medicines have incomplete same actions in improvement of pulmonary function and therapeutic effect.展开更多
目的:探讨慢性病病案管理模式对我国社区老年抑郁症患者疗效的影响。方法:采用随机对照研究方法,将年龄≥60岁,符合美国《精神障碍诊断与统计手册》(Diagnostic and Statistical Manual of Mental Disorder,Fourthedition,DSM-Ⅳ)抑郁...目的:探讨慢性病病案管理模式对我国社区老年抑郁症患者疗效的影响。方法:采用随机对照研究方法,将年龄≥60岁,符合美国《精神障碍诊断与统计手册》(Diagnostic and Statistical Manual of Mental Disorder,Fourthedition,DSM-Ⅳ)抑郁症诊断标准的120例老年抑郁症患者,随机分成干预组(N=60)和对照组(N=60)。干预组实行慢性病病案管理模式,即精神科医生、社区医生和病案管理员共同对老年抑郁症患者实施综合治疗方案,如健康教育、心理治疗和药物治疗等;对照组按照目前社区日常的医学方式进行。在治疗前,治疗第2、4、6、8、12周末分别应用汉密尔顿抑郁量表(Hamilton Depression Scale,HAMD-17)、临床疗效总评量表(ClinicalGlobalImpression,CGI)、治疗副反应量表(Treatment Emergent Symptom Scale,TESS)对两组患者的疗效和药物不良反应进行评定。结果:在治疗12周末,干预组患者HAMD-17总分[(14.19±7.66)vs.(24.93±5.86)]和CGI-GI评分[(1.61±0.92)vs.(3.43±1.42)]均低于对照组(均P<0.01);干预组有效率(83.1%vs.39.3%)、临床治愈率(27.1%vs.5.4%)高于对照组(均P<0.01);干预组患者坚持服药率高于对照组(98.3%vs.35%,P<0.01);两组患者药物不良反应轻微,且差异无统计学意义(P>0.05)。结论:应用慢性病病案管理模式可以有效地减轻抑郁症状,增加抗抑郁药的使用,提高治疗效果。展开更多
文摘OBJECTIVE:To evaluate clinical efficacy of point application or adjuvant therapy on chronic obstructive pulmonary disease in stationary phase and effects on pulmonary functions.METHODS:Computer retrieved CNKI,VIP,CBM and other databanks and manual operations retrieved correlative literatures to find randomized controlled trials(RCTs) about comparison between point application or adjuvant therapy and no-point-applications for treatment of chronic obstructive pulmonary disease in stationary phase in China.RevMan 5.0 software was used for Meta analysis.RESULTS:Among 3481 cases in the inclusive 32 RCTS,1780 cases were in the test group and 1701 cases in the control group.Meta analysis indicated:1) clinical efficacy:the groups containing point application therapy all were better than the groups of no-point-application;2) force vital capacity(FVC):There was no statistically significant difference between the group of point application plus Western Medicine and the Western Medicine group;3) force expiratory volume 1(FEV1):The groups containing point application therapy were better than the no-point-application;4) FEV1%:the groups of point application plus Western Medicine were better than the Western Medicine groups;5) FEV1/FVC:there was a significant difference between the group of point application plus Chinese drugs and the group of Chinese drug.CONCLUSION:Point application can increase clinical efficacy of chronic obstructive pulmonary disease in stationary phase in varying degrees,and different combinations of point application with Chinese drugs or Western Medicines have incomplete same actions in improvement of pulmonary function and therapeutic effect.
